|
1
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kamali Zonouzi S, Pezeshki PS, Razi S and
Rezaei N: Cancer-associated fibroblasts in colorectal cancer. Clin
Transl Oncol. 24:757–769. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mammes A, Pasquier J, Mammes O, Conti M,
Douard R and Loric S: Extracellular vesicles: General features and
usefulness in diagnosis and therapeutic management of colorectal
cancer. World J Gastrointest Oncol. 13:1561–1598. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen S, Fang Y, Sun L, He R, He B and
Zhang S: Long Non-coding RNA: A potential strategy for the
diagnosis and treatment of colorectal cancer. Front Oncol.
11:7627522021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang C, Liu J, Hu Q, Zeng S and Yu L:
Metastatic colorectal cancer: Perspectives on long non-coding RNAs
and promising therapeutics. Eur J Pharmacol. 908:1743672021.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Zhang X, Zhang J, Chen S, Zhu J
and Wang X: Long noncoding RNA CRART16 confers 5-FU resistance in
colorectal cancer cells by sponging miR-193b-5p. Cancer Cell Int.
21:6382021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo Z, Liu X and Shao H: E2F4-induced
AGAP2-AS1 up-regulation accelerates the progression of colorectal
cancer via miR-182-5p/CFL1 axis. Dig Liver Dis. 54:878–889. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bian Z, Zhou M, Cui K, Yang F, Cao Y, Sun
S, Liu B, Gong L, Li J, Wang X, et al: SNHG17 promotes colorectal
tumorigenesis and metastasis via regulating Trim23-PES1 axis and
miR-339-5p-FOSL2-SNHG17 positive feedback loop. J Exp Clin Cancer
Res. 40:3602021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding X, Xu X, He XF, Yuan Y, Chen C, Shen
XY, Su S, Chen Z, Xu ST and Huang YH: Muscleblind-like 1 antisense
RNA 1 inhibits cell proliferation, invasion, and migration of
prostate cancer by sponging miR-181a-5p and regulating
PTEN/PI3K/AKT/mTOR signaling. Bioengineered. 12:803–814. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Q, Wu Y, Chen J, Tan F, Mou J, Du Z,
Cai Y, Wang B and Yuan C: The regulatory role of both MBNL1 and
MBNL1-AS1 in several common cancers. Curr Pharm Des. 28:581–585.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu L, Zhu S, Tang A and Liu W: LncRNA
MBLN1-AS1 inhibits the progression of retinoblastoma through
targeting miR-338-5p-Wnt/β-catenin signaling pathway. Inflamm Res.
70:217–227. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu K, Wang Y, Liu L, Li S and Yu W: Long
non-coding RNA MBNL1-AS1 regulates proliferation, migration, and
invasion of cancer stem cells in colon cancer by interacting with
MYL9 via sponging microRNA-412-3p. Clin Res Hepatol Gastroenterol.
44:101–114. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parang B, Kaz AM, Barrett CW, Short SP,
Ning W, Keating CE, Mittal MK, Naik RD, Washington MK, Revetta FL,
et al: BVES regulates c-Myc stability via PP2A and suppresses
colitis-induced tumourigenesis. Gut. 66:852–862. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Williams CS, Zhang B, Smith JJ, Jayagopal
A, Barrett CW, Pino C, Russ P, Presley SH, Peng D, Rosenblatt DO,
et al: BVES regulates EMT in human corneal and colon cancer cells
and is silenced via promoter methylation in human colorectal
carcinoma. J Clin Invest. 121:4056–4069. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng Q, Hawes SE, Stern JE, Wiens L, Lu H,
Dong ZM, Jordan CD, Kiviat NB and Vesselle H: DNA methylation in
tumor and matched normal tissues from non-small cell lung cancer
patients. Cancer Epidemiol Biomarkers Prev. 17:645–654. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim M, Jang HR, Haam K, Kang TW, Kim JH,
Kim SY, Noh SM, Song KS, Cho JS, Jeong HY, et al: Frequent
silencing of popeye domain-containing genes, BVES and POPDC3, is
associated with promoter hypermethylation in gastric cancer.
Carcinogenesis. 31:1685–1693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jagannathan K, Calhoun VD, Gelernter J,
Stevens MC, Liu J, Bolognani F, Windemuth A, Ruaño G, Assaf M and
Pearlson GD: Genetic associations of brain structural networks in
schizophrenia: A preliminary study. Biol Psychiatry. 68:657–666.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jorgensen BG and Ro S: MicroRNAs and
‘sponging’ competitive endogenous RNAs dysregulated in colorectal
cancer: Potential as noninvasive biomarkers and therapeutic
targets. Int J Mol Sci. 23:21662022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su J, Chen D, Ruan Y, Tian Y, Lv K, Zhou
X, Ying D and Lu Y: LncRNA MBNL1-AS1 represses gastric cancer
progression via the TGF-β pathway by modulating miR-424-5p/Smad7
axis. Bioengineered. 13:6978–6995. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang H, Shi Z, Li Y, Zhu G, Chen C, Zhang
Z, Shi R, Su L, Cao P, Pan Z, et al: Pyroptosis-related LncRNA
signatures correlate with lung adenocarcinoma prognosis. Front
Oncol. 12:8509432022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Guo Y, Li S, Xu J, Wang X, Ning W,
Ma L, Qu Y, Zhang M and Zhang H: Identification of
N6-methyladenosine-related lncRNAs as a prognostic signature in
glioma. Front Oncol. 12:7892832022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sanaei MJ, Baghery Saghchy Khorasani A,
Pourbagheri-Sigaroodi A, Shahrokh S, Zali MR and Bashash D: The
PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations,
non-coding RNAs, therapeutic opportunities, and the emerging role
of nanoparticles. J Cell Physiol. 237:1720–1752. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao G, Tan B, Wei S, Shen W, Wang X, Chu
Y, Rong T and Gao C: Down-regulation of MBNL1-AS1 contributes to
tumorigenesis of NSCLC via sponging miR-135a-5p. Biomed
Pharmacother. 125:1098562020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei X, Yang X, Wang B, Yang Y, Fang Z, Yi
C, Shi L and Song D: LncRNA MBNL1-AS1 represses cell proliferation
and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1
axis in bladder cancer. Cancer Med. 9:724–736. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang J, Jiang G, Mao W, Huang L, Huang C,
Wang S, Xue H, Ke J and Ni Q: Up-regulation of long noncoding RNA
MBNL1-AS1 suppresses breast cancer progression by modulating
miR-423-5p/CREBZF axis. Bioengineered. 13:3707–3723. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han P, Fu Y, Liu J, Wang Y, He J, Gong J,
Li M, Tan Q, Li D, Luo Y, et al: Netrin-1 promotes cell migration
and invasion by down-regulation of BVES expression in human
hepatocellular carcinoma. Am J Cancer Res. 5:1396–1409.
2015.PubMed/NCBI
|
|
28
|
Li C, Wang P, Du J, Chen J, Liu W and Ye
K: LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed
proliferation, invasion and glycolysis of colorectal cancer. IUBMB
Life. 73:286–298. 2021. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rapado-González Ó, Majem B, Álvarez-Castro
A, Díaz-Peña R, Abalo A, Suárez-Cabrera L, Gil-Moreno A, Santamaría
A, López-López R, Muinelo-Romay L and Suarez-Cunqueiro MM: A novel
saliva-based miRNA signature for colorectal cancer diagnosis. J
Clin Med. 8:20292019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jin Y, Xu L, Zhao B, Bao W, Ye Y, Tong Y,
Sun Q and Liu J: Tumour-suppressing functions of the lncRNA
MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells. Cell
Cycle. 21:908–920. 2022. View Article : Google Scholar : PubMed/NCBI
|
